AMGN Competitors
Amgen Inc.
$426.11
+$13.27(+3.21%)
65
Overall
80
Value
63
Tech
52
Quality
Market Cap
$230.37B
Volume
3.05M
52W Range
$288.00 - $447.03
Target Price
$403.61
AMGN competitors: BMY, PFE, GSK, GILD, ABBV. Amgen Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
AMGN Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| BMY Bristol-Myers Squibb Company | $59.28 | $121.09B | $6.80 | 3.19% | 63 |
| PFE Pfizer Inc. | $29.21 | $166.49B | $2.96 | 5.89% | 70 |
| GSK GSK plc | $47.87 | $94.64B | $4.78 | 3.79% | 33 |
| GILD Gilead Sciences, Inc. | $153.54 | $190.38B | $-0.47 | 2.12% | 73 |
| ABBV AbbVie Inc. | $283.48 | $500.94B | $13.94 | 2.41% | 70 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AMGN | $426.11 | +3.2% | 3.05M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |